ARTICLE | Company News
MDxHealth, Predictive Biosciences deal
December 6, 2010 8:00 AM UTC
MDxHealth granted Predictive Biosciences exclusive, U.S. rights to undisclosed DNA methylation biomarkers for use in urine-based CertNDx Bladder Cancer Assay. MDxHealth retains exclusive, ex-U.S. righ...